Log in
Enquire now
‌

US Patent 9873700 Compounds for kinase modulation, and indications therefor

Patent 9873700 was granted and assigned to Plexxikon Inc. on January, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Plexxikon Inc.
Plexxikon Inc.
0
Current Assignee
Plexxikon Inc.
Plexxikon Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
98737000
Patent Inventor Names
Chao Zhang0
Prabha N. Ibrahim0
Songyuan Shi0
Wayne Spevak0
Elizabeth A. Burton0
Gaston G. Habets0
Klaus-Peter Hirth0
Marika Nespi0
Date of Patent
January 23, 2018
0
Patent Application Number
142907860
Date Filed
May 29, 2014
0
Patent Citations Received
‌
US Patent 12076322 Compounds and methods for kinase modulation, and indications therefor
0
Patent Primary Examiner
‌
Marcos Sznaidman
0
Patent abstract

Compounds active on protein kinases and methods for regulating protein kinase pathways are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9873700 Compounds for kinase modulation, and indications therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.